Table 2 Characteristics of the validation cohorts.
From: TCTEX1D1 is a genetic modifier of disease progression in Duchenne muscular dystrophy
Age | Ambulation | Corticosteroids | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mean | Min | Med | Max | Ambulant | Non ambulant | Not treated | Treated | Unknown | ||||||
N | Row % | N | Row % | N | Row % | N | Row % | Count | Row % | |||||
BIO-NMD cohort | ||||||||||||||
Newcastle | 10.11 | 2.9 | 10 | 17.1 | 30 | 39.50% | 46 | 60.50% | 35 | 46.10% | 34 | 44.70% | 7 | 9.20% |
London | 10.53 | 4 | 11 | 15 | 7 | 13.00% | 47 | 87.00% | 32 | 59.30% | 21 | 38.90% | 1 | 1.90% |
Ferrara | 9.86 | 3.8 | 10 | 17 | 0 | 0.00% | 62 | 100.00% | 30 | 48.40% | 13 | 21.00% | 19 | 30.60% |
Montpellier | 9.56 | 5.8 | 9 | 14 | 0 | 0.00% | 42 | 100.00% | 36 | 85.70% | 2 | 4.80% | 4 | 9.50% |
Leiden | 9.31 | 4 | 9 | 13 | 17 | 25.40% | 50 | 74.60% | 36 | 53.70% | 27 | 40.30% | 4 | 6.00% |
CINRG cohort (European Ancestry sub-cohort) | 12.53 | 3 | 11.4 | 25.7 | 40 | 36.70% | 69 | 63.30% | 22 | 20.20% | 87 | 79.80% | 0 | 0% |
